Gene Devane
Foot & Ankle Surgery · Bloomington, INNPI 1518198639
Payments from drug & device makers
Across 68 payments — averaging $23.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$198
- Tactile Systems Technology Inc$179
- Access Pro Medical, LLC$177
- Kerecis Limited$161
- Smith+Nephew$125
- Linvatec Corporation$114
- plus $657 from 16 others
What the payments were for
- Food & beverage$1,611100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 6 | $198 |
| Tactile Systems Technology Inc | 14 | $179 |
| Access Pro Medical, LLC | 2 | $177 |
| Kerecis Limited | 6 | $161 |
| Smith+Nephew | 5 | $125 |
| Linvatec Corporation | 1 | $114 |
| Paratek Pharmaceuticals, Inc. | 6 | $98 |
| Azurity Pharmaceuticals, Inc. | 4 | $76 |
| Vertex | 3 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Orthofix Medical, Inc. | 3 | $44 |
| Exact Sciences | 2 | $41 |
| Johnson & Johnson | 1 | $34 |
| Urgo Medical North America, LLC | 2 | $33 |
| Organogenesis Inc. | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Integra Lifesciences Corporation | 1 | $31 |
| Bioventus LLC | 1 | $26 |
| Averitas Pharma Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| AbbVie | 1 | $22 |
| TELA Bio, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Matriderm$168
- BioBrace 23mm$114
- COLINK 2$114
- IBS$114
- QUANTUM$114
- HERCULES SUTURE ANCHOR SYSTEM$114
How this compares
$1,611 in reported general payments places this provider in the 25th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 119 | $2,671 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 118 | $1,389 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 44 | $863 |
| Lidocaine | 11 | $741 |
| Cefdinir | 20 | $668 |
| Cephalexin | 51 | $474 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $395 |
| Pentoxifylline | 12 | $381 |
| Terbinafine Hcl | 30 | $369 |
| Clindamycin Hcl | 47 | $342 |
| Ketoconazole | 11 | $297 |
| Methylprednisolone | 44 | $266 |
| Ciprofloxacin Hcl | 24 | $230 |
| Ondansetron Hcl | 33 | $219 |
| Mupirocin | 30 | $209 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bloomington
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Christopher WintersCarmel$158K
- Steven DouthettFort Wayne$153K
- Brian ElliottShelbyville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.